Report overview
Biologics for the prevention of mycoplasma pneumonia in pigs
This report contains market size and forecasts of Swine Mycoplasma Hyopneumoniae Vaccine in global, including the following market information:
Global Swine Mycoplasma Hyopneumoniae Vaccine Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Swine Mycoplasma Hyopneumoniae Vaccine Market Sales, 2018-2023, 2023-2030, (Box)
Global top five Swine Mycoplasma Hyopneumoniae Vaccine companies in 2022 (%)
The global Swine Mycoplasma Hyopneumoniae Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Swine Pseudorabies Vaccine, Live Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Swine Mycoplasma Hyopneumoniae Vaccine include Yongshun Creatures, Pfizer, Boehringer Ingelheim, Bayer, Elanco, MSD, Cahic, Ringpu and Baoling, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Swine Mycoplasma Hyopneumoniae Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Swine Mycoplasma Hyopneumoniae Vaccine Market, by Activity, 2018-2023, 2023-2030 ($ Millions) & (Box)
Global Swine Mycoplasma Hyopneumoniae Vaccine Market Segment Percentages, by Activity, 2022 (%)
Swine Pseudorabies Vaccine, Live
Swine Pseudorabies Vaccine, Inactivated
Global Swine Mycoplasma Hyopneumoniae Vaccine Market, by Downstream, 2018-2023, 2023-2030 ($ Millions) & (Box)
Global Swine Mycoplasma Hyopneumoniae Vaccine Market Segment Percentages, by Downstream, 2022 (%)
Farms
Individual
Global Swine Mycoplasma Hyopneumoniae Vaccine Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Box)
Global Swine Mycoplasma Hyopneumoniae Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Swine Mycoplasma Hyopneumoniae Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Swine Mycoplasma Hyopneumoniae Vaccine revenues share in global market, 2022 (%)
Key companies Swine Mycoplasma Hyopneumoniae Vaccine sales in global market, 2018-2023 (Estimated), (Box)
Key companies Swine Mycoplasma Hyopneumoniae Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Yongshun Creatures
Pfizer
Boehringer Ingelheim
Bayer
Elanco
MSD
Cahic
Ringpu
Baoling
Jizhong
Dahuanong
Keqian Biology
Hayao
Pulike Biology
Tecon
